07.28.25 -- FDA Trials And Tribulations With Connect Biopharma's Barry Quart

While Japan's current HTA system is seen as pro-innovation, potential reforms in 2026 could expand its scope, creating uncertainty for manufacturers in one of the world's largest markets.

By shifting from reactive problem-solving to proactive planning, predictive intelligence ensures clinical trials meet their enrollment goals more efficiently.

Despite growing sustainability efforts, our industry lags in climate goals, especially Scope 3 emissions. Discover why bold action and deep collaboration across the value chain are essential for real progress.

Review the advancing mass spectrometry, biophysical characterization, automated sample preparation, and high throughput analytics required to deliver medicines in a safe, compliant, and efficient manner.

Increasing clinical trial diversity requires community engagement, simplified trial information, and collaboration to build trust and create accessible pathways for patient participation.

What is the direct-to-patient (DtP) recruitment, and how can sponsors and organizers leverage this approach to boost patient recruitment and achieve clinical trial goals?